聚乙二醇
药物输送
人造眼泪
药品
材料科学
生物利用度
生物医学工程
化学
医学
眼科
药理学
纳米技术
有机化学
作者
Xiaoyan Xu,Sahar Awwad,Luis Diaz-Gomez,Carmen Alvarez-Lorenzo,Steve Brocchini,Simon Gaisford,Alvaro Goyanes,Abdul Basit
出处
期刊:Pharmaceutics
[MDPI AG]
日期:2021-09-08
卷期号:13 (9): 1421-1421
被引量:7
标识
DOI:10.3390/pharmaceutics13091421
摘要
Dry eye disease is a common ocular disorder that is characterised by tear deficiency or excessive tear evaporation. Current treatment involves the use of eye drops; however, therapeutic efficacy is limited because of poor ocular bioavailability of topically applied formulations. In this study, digital light processing (DLP) 3D printing was employed to develop dexamethasone-loaded punctal plugs. Punctal plugs with different drug loadings were fabricated using polyethylene glycol diacrylate (PEGDA) and polyethylene glycol 400 (PEG 400) to create a semi-interpenetrating network (semi-IPN). Drug-loaded punctal plugs were characterised in terms of physical characteristics (XRD and DSC), potential drug-photopolymer interactions (FTIR), drug release profile, and cytocompatibility. In vitro release kinetics of the punctal plugs were evaluated using an in-house flow rig model that mimics the subconjunctival space. The results showed sustained release of dexamethasone for up to 7 days from punctal plugs made with 20% w/w PEG 400 and 80% w/w PEGDA, while punctal plugs made with 100% PEGDA exhibited prolonged releases for more than 21 days. Herein, our study demonstrates that DLP 3D printing represents a potential manufacturing platform for fabricating personalised drug-loaded punctal plugs with extended release characteristics for ocular administration.
科研通智能强力驱动
Strongly Powered by AbleSci AI